Evidence map›Paper›PMID 40421160›Full record

ArticleComputational and structural biotechnology journal2025

Combining long-read DNA and RNA sequencing to enhance molecular understanding of structural variations leading to copy gains.

Jade Fauqueux, Jean-Pascal Meneboo, Roseline Caumes, Luc Thomès, Emilie Ait Yahya, Caroline Thuillier, Elise Boudry, Celine Villenet, Martin Figeac, Jamal Ghoumid and 1 more

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jade FauqueuxULR 7364-RADEME, Univ. Lille, FHU-G4 Génomique, Lille F-59000, France.
Jean-Pascal MenebooUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014-PLBS, FHU-G4 Génomique, Lille F-59000, France.
Roseline CaumesULR 7364-RADEME, Univ. Lille, FHU-G4 Génomique, Lille F-59000, France.
Luc ThomèsULR 7364-RADEME, Univ. Lille, FHU-G4 Génomique, Lille F-59000, France.
Emilie Ait YahyaCHU Lille, Cellule de Bioinformatique, Plateau Commun de Séquençage, CHU Lille, Lille F-59000, France.
Caroline ThuillierCHU Lille, Institut de Génétique Médicale, Lille, Lille F-59000, France.
Elise BoudryCHU Lille, Institut de Génétique Médicale, Lille, Lille F-59000, France.
Celine VillenetUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014-PLBS, FHU-G4 Génomique, Lille F-59000, France.
Martin FigeacUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014-PLBS, FHU-G4 Génomique, Lille F-59000, France.
Jamal GhoumidULR 7364-RADEME, Univ. Lille, FHU-G4 Génomique, Lille F-59000, France.
Thomas SmolULR 7364-RADEME, Univ. Lille, FHU-G4 Génomique, Lille F-59000, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Structural variants (SVs) significantly contribute to human disease, but their complexity often makes accurate characterization difficult with conventional methods. Advances in long-read sequencing (LRS) offer potential by spanning kilobases and directly resolving SVs. In this study, we examined two individuals with unresolved SVs. LRS on both DNA and cDNA provided single-base resolution of all breakpoint junctions, revealing detailed rearrangement structures and underlying mechanisms. Transcriptomic analyses identified abnormal fusion transcripts and clarified their functional consequences, including haploinsufficiency and potential dominant-negative effects. In one case, a triplication affecting the

Indexed as

CytogenomicsLong Read SequencingNanoporeREREZMYM2

Identifiers

PMID40421160
PMCPMC12104687

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.